Real-world performance of the MiniMed™ 780G system: first report of outcomes from 4120 users
JD Silva, G Lepore, T Battelino, A Arrieta… - Diabetes Technology …, 2022 - liebertpub.com
Background: The MiniMed™ 780G system includes an advanced hybrid closed loop (AHCL)
algorithm that provides both automated basal and correction bolus insulin delivery. The …
algorithm that provides both automated basal and correction bolus insulin delivery. The …
Hybrid closed‐loop therapy: Where are we in 2021?
Hybrid closed‐loop systems are characterized by the coexistence of algorithm‐driven
automated insulin delivery combined with manual mealtime boluses. Used correctly, these …
automated insulin delivery combined with manual mealtime boluses. Used correctly, these …
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
RM Bergenstal, R Nimri, RW Beck, A Criego, L Laffel… - The Lancet, 2021 - thelancet.com
Background Management of type 1 diabetes is challenging. We compared outcomes using a
commercially available hybrid closed-loop system versus a new investigational system with …
commercially available hybrid closed-loop system versus a new investigational system with …
Rapid improvement in time in range after the implementation of an advanced hybrid closed-loop system in adolescents and adults with type 1 diabetes
PI Beato-Víbora, F Gallego-Gamero… - Diabetes Technology …, 2021 - liebertpub.com
Background: Advanced hybrid closed-loop (AHCL) systems represent the next step of
automation intended to maximize normoglycemia in people with type 1 diabetes (T1D). In …
automation intended to maximize normoglycemia in people with type 1 diabetes (T1D). In …
A clinical review of the t: slim X2 insulin pump
C Berget, S Lange, L Messer… - Expert Opinion on Drug …, 2020 - Taylor & Francis
Insulin pumps are commonly used for intensive insulin therapy to treat type 1 diabetes in
adults and youth. Insulin pump technologies have advanced dramatically in the last several …
adults and youth. Insulin pump technologies have advanced dramatically in the last several …
Glycemic outcomes of advanced hybrid closed loop system in children and adolescents with type 1 diabetes, previously treated with multiple daily injections (MiniMed …
G Petrovski, F Al Khalaf, J Campbell, E Day… - BMC endocrine …, 2022 - Springer
Background The objective of this study was to evaluate the glycemic outcomes in children
and adolescents with Type 1 Diabetes (T1D) previously treated with Multiple Daily Injections …
and adolescents with Type 1 Diabetes (T1D) previously treated with Multiple Daily Injections …
Artificial pancreas systems: experiences from concept to commercialisation
DL Rodríguez-Sarmiento, F León-Vargas… - Expert Review of …, 2022 - Taylor & Francis
Introduction Automated insulin delivery (AID) systems, known as artificial pancreas or closed-
loop glucose control systems, have been developed to improve the glycemic outcomes of …
loop glucose control systems, have been developed to improve the glycemic outcomes of …
Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting
PI Beato-Víbora, F Gallego-Gamero… - Diabetes Research and …, 2021 - Elsevier
Aims Automation in diabetes technology is rapidly evolving. The aim was to evaluate the
real-world glycemic outcomes and user acceptance after 3 months of using the Medtronic …
real-world glycemic outcomes and user acceptance after 3 months of using the Medtronic …
Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus
G Tornese, F Buzzurro, C Carletti… - Frontiers in …, 2021 - frontiersin.org
Introduction The purpose of this study was to assess the effectiveness of advanced-(a-HCL)
vs. standard-hybrid closed-loop (s-HCL) systems use up to 6 months of treatment in a real …
vs. standard-hybrid closed-loop (s-HCL) systems use up to 6 months of treatment in a real …
Fast-acting insulin aspart versus insulin aspart using a second-generation hybrid closed-loop system in adults with type 1 diabetes: a randomized, open-label …
MH Lee, B Paldus, S Vogrin, D Morrison… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE To evaluate glucose control using fast-acting insulin aspart (faster aspart)
compared with insulin aspart (IAsp) delivered by the MiniMed Advanced Hybrid Closed …
compared with insulin aspart (IAsp) delivered by the MiniMed Advanced Hybrid Closed …